Asset sale Completed
Rovi acquisition of Manufacturing facility in Phoenix, AZ
Announced Mar 2026 (approx.)
Advisers
Manufacturing facility in Phoenix, AZ
Target
Not disclosed
Rovi
Acquirer
Not disclosed
Other advisers
- Financial adviser
- Target
- Manufacturing facility in Phoenix, AZ
- Acquirer
- Rovi
- Seller
- Bristol Myers Squibb
- Target based in
- United States
- Buyer based in
- Spain
- Seller based in
- United States
- Completed
- Mar 2026
- Sector
- Pharmaceutical Manufacturing
- Tags
- Pharmaceutical Manufacturing, Pharma
In the league tables
Similar deals
- Cheplapharm acquisition of portfolio of 20 mature medicines and three manufacturing sites Sep 2026 · Pharma
- Aurobindo acquisition of Lannett Jul 2026 · US$250m · Pharma
- PAI Pharma acquisition of Nivagen Pharmaceuticals Jan 2026 · Pharmaceutical Manufacturing
- ACS Dobfar acquisition of Istituto Biochimico Italiano Giovanni Lorenzini (IBI Lorenzini) 2026 · Pharmaceutical Manufacturing
- GTCR acquisition of Zentiva Sep 2025 · Pharma
Sources
- Mar 2026 William Blair: Bristol Myers Squibb has sold its manufacturing facility in Phoenix, AZ to Rovi williamblair.com
